SCHEMBL9947475

SCHEMBL9947475

O=Cc1cc(CO)ccc1OCc1ccc(F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
MAPT P10636 1/20 0.47
MAOA P21397 1/20 0.47
MAOB P27338 1/20 0.47
CCR5 P51681 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
HPGD P15428 1/20 0.45
KMT2A Q03164 3/20 0.44
MEN1 O00255 1/20 0.44
PTPN1 P18031 3/20 0.44
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
FFAR1 O14842 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41
PTPN7 P35236 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5631333 0.88 MAOA (0.51) ALDH1A1MAPTMAOAMAOBCCR5
SCHEMBL20742640 0.87 CCNB2 (0.51) MAPTSMN1; SMN2NPC1RAB9AHPGD
SCHEMBL5628019 0.82 MAPT (0.51) ALDH1A1MAPTMAOAMAOBCCR5
SCHEMBL12437548 0.82 MAOA (0.47) ALDH1A1MAPTMAOAMAOBCCR5
SCHEMBL30866193 0.82 CCR5 (0.62) ALDH1A1MAPTMAOAMAOBCCR5
SCHEMBL275887 0.82 CCR5 (0.62) ALDH1A1MAPTMAOAMAOBCCR5
SCHEMBL5465784 0.82 SLC6A4 (0.52) ALDH1A1MAPTMAOAMAOBCCR5
SCHEMBL9947480 0.81 MAPT (0.55) ALDH1A1MAPTCCR5SMN1; SMN2NPC1
SCHEMBL30873551 0.80 MAOB (0.55) ALDH1A1MAPTMAOAMAOBSMN1; SMN2
SCHEMBL5629722 0.80 PTPN1 (0.54) MAPTMAOAMAOBPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120189545-A1 ISOTOPICALLY-LABELED BENZOFURAN COMPOUNDS AS IMAGING AGENTS FOR AMYLOIDOGENIC PROTEINS UNIVERSITY OF PITTSBURGH -- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2012-07-26 US disclosed
US-20120148494-A1 ISOTOPICALLY-LABELED BENZOFURAN COMPOUNDS AS IMAGING AGENTS FOR AMYLOIDOGENIC PROTEINS UNIVERSITY OF PITTSBURGH -- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120148494-A1 ISOTOPICALLY-LABELED BENZOFURAN COMPOUNDS AS IMAGING AGENTS FOR AMYLOIDOGENIC PROTEINS BACE1, APP, BACE2 ALDH1A1 2219/4885MAPT 14/4885MAOA 2440/4885
US-20120189545-A1 ISOTOPICALLY-LABELED BENZOFURAN COMPOUNDS AS IMAGING AGENTS FOR AMYLOIDOGENIC PROTEINS BACE1, APP, BACE2 ALDH1A1 2172/4885MAPT 16/4885MAOA 2032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.